Hyperthyroidism

Hyperthyroidism

 
Considering the symptoms presented by Ms. F, it can be seen that she is suffering from
Graves’ disease type of hyperthyroidism. The first-line treatment that can be recommended is the
administration of Calcium channel blockers. However, sometimes magnesium sulfate is used as
the best drug of choice depending on the symptoms presented. In the management and treatment
of cardiac rhythm, amiodarone drugs should be avoided (Taylor et al., 2018). It is because it
inhibits T4 to T3 peripheral de-ionization which results in a decrease of active thyroid hormone
concentration thus not suitable for use in patients with thyroid dysfunction.
The top priorities of care for the patient include; Monitoring the ECG for rate, rhythm, and
conduction, conducting cardioversion, Assessing the vital signs and reporting the abnormal changes
to the clinician, Obtaining an order for oxygen per nasal cannula adjusted to oxygen saturation and
finally the nurse can offer health education to the patient and the family concerning the importance
of reducing rapid heart rate (Lane et al., 2020). Tachycardia management and treatment involve
controlling the heart rhythm and it involves making proper phases to inhibit the heart from thumping
too fast. This may involve, the use of implanted devices, some medications, or other procedures and
surgeries. Drugs to control and restore the heart rate to a normal heart rhythm are normally
recommended for most individuals with tachycardia.
Yes, the nurse should be concerned about cardiac catheterization since it can cause severe
complications and damage to the heart of the patient. The nurse should also anticipate several
complications related to cardiac catheterization such as both acute and chronic kidney injury and
disease, fever, systematic infections, allergy, coagulopathy, unrestrained hypertension, and
arrhythmia.

3

References

Lane, L. C., Cheetham, T. D., Perros, P., & Pearce, S. H. (2020). New therapeutic horizons for
Graves’ hyperthyroidism. Endocrine Reviews, 41(6), 873-884.
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., &
Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and
hypothyroidism. Nature Reviews Endocrinology, 14(5), 301-316.